LONDON--(BUSINESS WIRE)--The global neuroscience antibodies and assays market is poised to grow by USD 1.36 billion during 2020-2024, progressing at a CAGR of over 8% during the forecast period. Request free sample pages
Read the 151-page report with TOC on "Neuroscience Antibodies and Assays Market Analysis Report by Product (Consumables and Instruments), Geographic Segmentation (Asia, Europe, North America, and ROW), and the Segment Forecasts, 2020-2024".
The market is driven by the technological advances. In addition, the advances in neuroscience instruments is anticipated to boost the growth of the neuroscience antibodies and assays market.
Technological advancements in recent years have led to the emergence of immunoassay analyzers. These analyzers have significantly changed with the development of new automated systems designed to run ELISAs, reduced assay step protocols, and production of no-wash ELISAs. Automated immunoassay systems simplify several key steps including incubations, reagent additions, and detection and data management. This minimizes the time, labor, and human errors and improves the efficiency of the immunoassay workflow. Thus, such technological advances is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Neuroscience Antibodies and Assays Market Companies:
Abcam Plc is headquartered in the UK and operates the business under the Sales of antibodies and related product segment. The company offers a wide range of primary antibodies which includes monoclonal antibodies such as Anti-CNPase antibody, Anti-Iba1 antibody.
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. is headquartered in the US and offers products through the following business units: Life Science and Clinical Diagnostics. The company offers Neuroscience development and repair antibodies, Neurodegeneration and Neurological Disease; Neuronal and Glial Markers; Neurotransmitters, receptors, and transporters; Myelin basic protein (MBP) antibodies, and F4/80 Antibodies.
Cell Signaling Technology Inc.
Cell Signaling Technology Inc. is headquartered in the US and operates under various business segments, namely Products and Services. The company offers wide range of products used in the various research applications of neurosciences.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. is headquartered in Switzerland and offers products through the following business segments: Pharmaceuticals and Diagnostics. The company offers Elecsys β-Amyloid (1-42) CSF and Research reagents.
GenScript Biotech Corp.
GenScript Biotech Corp. is headquartered in the US and offers products through the following business segments: Bio-science services and products, Biologics development service, Industrial synthetic biology products, and Cell therapy. The company offers Alzheimer's disease antibodies, Parkinson's disease, and Amyotrophic lateral sclerosis (ALS).
Register for a free trial today and gain instant access to 17,000+ market research reports.
Neuroscience Antibodies and Assays Market Product Outlook (Revenue, USD Billion, 2020-2024)
Neuroscience Antibodies and Assays Market Geographic Outlook (Revenue, USD Billion, 2020-2024)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Health Care Include:
In-vitro Toxicity Testing Market – Global In-vitro Toxicity Testing Market by end-users (pharmaceutical and biotechnology companies, academic and research institutions, and others) and geography (Asia, Europe, North America, and ROW).
Genetic Testing Market – Global Genetic Testing Market by geography (Asia, Europe, North America, and ROW), product (equipment and consumables), end-user (clinical diagnostics laboratories, hospitals, and biopharmaceutical companies and research centers), and application (predictive and diagnostic testing, prenatal, newborn, and preimplantation testing; pharmacogenomic testing; and forensic, relationship, and ancestry testing).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.